首页> 外文期刊>Journal of applied clinical medical physics / >Preclinical assessment of comfort and secure fit of thermobrachytherapy surface applicator (TBSA) on volunteer subjects
【24h】

Preclinical assessment of comfort and secure fit of thermobrachytherapy surface applicator (TBSA) on volunteer subjects

机译:临床前评估热近距离表面施涂器(TBSA)在志愿者受试者上的舒适度和牢固度的原因

获取原文
           

摘要

A thermobrachytherapy surface applicator (TBSA) was developed for simultaneous heat and brachytherapy treatment of chest wall (CW) recurrence of breast cancer. The ability to comfortably secure the applicator over the upper torso relative to the CW target throughout treatment is assessed on volunteers. Male and postmastectomy female volunteers were enrolled to evaluate applicator secure fit to CW. Female subjects with intact breast were also enrolled to assess the ability to treat challenging cases. Magnetic resonance (MR) images of volunteers wearing a TBSA over the upper torso were acquired once every 15 minutes for 90 minutes. Applicator displacement over this time period required for treatment preplanning and delivery was assessed using MR visible markers. Applicator comfort and tolerability were assessed using a questionnaire. Probability estimates of applicator displacements were used to investigate dosimetric impact for the worst‐case variation in radiation source‐to‐skin distance for 5 and 10 mm deep targets spread on a torso phantom. Average and median displacements along lateral and radial directions were less than 1.2 mm over 90 minutes for all volunteers. Maximum lateral and radial displacements were measured to be less than 1 and 1.5 mm, respectively, for all CW volunteers and less than 2 mm for intact breast volunteers, excluding outliers. No complaint of pain or discomfort was reported. Phantom treatment planning for the maximum displacement of 2 mm indicated increase in skin dose with loss of homogeneity index (HI) for ‐2 mm uniform HDR source displacement. For +2 mm uniform displacement, skin dose decreased and HI increased by 20%. The volunteer study demonstrated that such large and uniform displacements should be rare for CW subjects, and the measured variation is expected to be low for multifraction conformal brachytherapy treatment. PACS numbers: 41.20.Jb, 41.75.‐i, 44.
机译:开发了一种热近距离放射治疗表面涂药器(TBSA),用于同时加热和近距离放射治疗乳腺癌的胸壁(CW)复发。在志愿者中评估了在整个治疗过程中相对于CW目标舒适地将施药器固定在上躯干上的能力。男性和乳房切除术后女性志愿者被招募到评估涂药器对CW的安全配合。乳房完整的女性受试者也被纳入评估治疗挑战性病例的能力。每隔15分钟采集一次TBSA穿上躯干的志愿者的磁共振(MR)图像,持续90分钟。使用MR可见标记评估在治疗前计划和交付所需的这段时间内涂药器的位移。使用问卷评估涂药器的舒适度和耐受性。涂药器位移的概率估计用于调查在人体模型上散布的5 mm和10 mm深目标的辐射源到皮肤距离的最坏情况变化的剂量学影响。所有志愿者在90分钟内沿横向和径向的平均位移和中位位移小于1.2毫米。对于所有CW志愿者,测得的最大横向和径向位移分别小于1和1.5 mm,而完整乳房志愿者(不包括异常值)的最大横向和径向位移小于2 mm。没有抱怨疼痛或不适的报道。对于2 mm的最大位移的幻影治疗计划表明,对于‐ 2 mm的均匀HDR源位移,皮肤剂量会增加,且均质性指数(HI)会下降。对于+2 mm的均匀位移,皮肤剂量减少,HI增加20%。这项自愿研究表明,这种连续性大而均匀的位移对于连续波受试者来说应该是很少的,并且对于多部分保形近距离放射治疗,所测得的变化预计很小。 PACS编号:41.20.Jb,41.75.-i,44。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号